
Nemysis – FreeMind Elite
January 6, 2025/by Ayal Ronen
4J Therapeutics – FreeMind Elite
January 6, 2025/by Ayal Ronen
NIH Funding during the first Trump Administration; Driving Growth in Non-Basic Research and Supporting the Life Sciences Industry
December 18, 2024/by Ayal Ronen
4J Therapeutics Secures Major BARDA Contract
November 6, 2024/by Ayal Ronen
Grant Tips & Tricks: Straight from the FreeMind Group Experts
October 10, 2024/by Ayal Ronen
LSX Nordic Congress, October 8-9, 2024, Copenhagen, Denmark
September 29, 2024/by Ayal Ronen
Cell & Gene on the Mesa, October 7-9, 2024, Phoenix, AZ
September 29, 2024/by Ayal Ronen
LSX RNA Leaders, September 4-5, 2024, San Diego
July 24, 2024/by Ayal Ronen
LSX World Congress USA, September 11-12, 2024, Boston
July 15, 2024/by Ayal Ronen
Why Should the Government Fund R&D?
July 15, 2024/by Ayal Ronen
The MedTech Conference, October 15-17, Toronto
June 23, 2024/by Ayal Ronen
The Benefits of Non-Dilutive Funding
June 19, 2024/by Ayal RonenSearch
Recent Posts
Sachs Associates BEF, Basel, Switzerland, October 7-8, 2026September 27, 2026 - 6:51 am
Sachs Associates EHIS, Basel, October 6, 2026September 27, 2026 - 6:48 am
BioFuture, October 27-28, 2026, NYCAugust 2, 2026 - 6:59 am
RESI Boston, September 22-23, 2026, Boston, USAJuly 30, 2026 - 8:42 am
LSX USA Congress, September 23-24, 2026, Boston, USAJuly 30, 2026 - 8:37 am
